|
Ladnaia N.N., Pokrovsky V.V., Sokolova E.V., Chekryzhova D.G., Kirzhanova V.V.
Prevalence of human immune deficiency virus infection in the territories of the Russian Federation in 2021
|
№3 / 2022
|
|
Stepanova E.V., Leonova O.N., Buzunova S.A.
Analysis of the established disability group in HIV-infected patients
|
№1 / 2022
|
|
Belyaeva V.V., Kozyrina N.V., Sokolova E.V., Semikova S.Yu., Galiullin N.I., Bekbolotov A.A., Beshimov A.T., Berdalieva T.Ch., Narkevich A.N., Lebedeva E.P., Suvorova Z.K., Khokhlova O.N., Shegai M.M.
HIV treatment adherence technology: analysis of communications in the specialist-patient system
|
№1 / 2022
|
|
Malashenko A.A., Krasnov K.A., Krasnov O.A.
A surgeon's tactics in the diagnosis of fractures in HIV-infected patients. a clinical case of clavicular tuberculous lesion with pathological fracture
|
№4 / 2021
|
|
Matievskaya N.V., Dolinskaya O.V.
Experience with a dual ART regimen in an elderly female patient with HIV infection
|
№4 / 2021
|
|
Sokolova E.V., Belyaeva V.V., Kozyrina N.V., Galiullin N.I., Semikova S.Yu., Beshimov A.T., Lebedeva E.P., Khoraskina E.А., Narkevich A.N., Gavrilova O.V., Suvorova Z.К., Khokhlova O.N.
Self-assessment of health status as a factor for the prediction of adherence to follow-up and treatment of HIV infection: results of correlation analysis
|
№4 / 2021
|
|
Kanestri V.G., Kravchenko A.V., Pokrovskaya A.V., Kulabukhova E.I., Kuimova U.A., Goliusova M.D., Kozyrina N.V., Shakhgildyan V.I., Yurin O.G.
Randomized, open-label, controlled, comparative study on switching HIV-infected patients with their antiretroviral therapy experience to a DTG and 3TC regimen: 96-weeks results
|
№4 / 2021
|
|
Kravchenko A.V., Kuimova U.A., Kanestri V.G., Goliusova M.D., Kulabukhova E.I.
The clinical course of HIV/COVID-19 co-infection and approaches to its therapy
|
№4 / 2021
|
|
Ladnaia N.N., Pokrovsky V.V., Sokolova E.V., Chekryzhova D.G.
Prevalence of HIV infection among injecting drug users in the Siberian Federal District
|
№4 / 2021
|
|
Orlova-Morozova E.A., Pronin A.Yu.
The use of doravirine as part of antiretroviral therapy regimens in patients with resistance mutations
|
№3 / 2021
|
|
Kravchenko A.V., Pokrovskaya A.V., Kuimova U.A., Kanestri V.G., Deulina M.O., Goliusova M.D., Kulabukhova E.I., Kozyrina N.V., Yurin O.G.
Results of treatment with a 60-week Russian ART regimen in patients with HIV infection
|
№3 / 2021
|
|
Ermak T.N.
Cutaneous leishmaniasis in patients with HIV infection
|
№3 / 2021
|
Русский
